SAM
ADPT icon

Smartleaf Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Smartleaf Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94K Hold
4,393
– – ﹤0.01% 1203
2026
Q1 		$56.5K Buy
4,393
+38
+0.9% +$605 ﹤0.01% 1394
2025
Q4 		$71.5K Buy
4,355
+416
+11% +$6.79K ﹤0.01% 1373
2025
Q3 		$53K Buy
3,939
+3,371
+593% +$41.1K ﹤0.01% 1368
2025
Q2 		$6.7K Sell
568
-40
-7% -$363 ﹤0.01% 1954
2025
Q1 		$4.66K Sell
608
-1
-0.2% -$8 ﹤0.01% 2210
2024
Q4 		$3.72K Hold
609
– – ﹤0.01% 2351
2024
Q3 		$3.04K Buy
609
+37
+6% +$161 ﹤0.01% 2332
2024
Q2 		$1.98K Buy
+572
New +$1.82K ﹤0.01% 2229

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Smartleaf Asset Management's ADPT Position: Q2 2026 in Review

Smartleaf Asset Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 4,393 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Smartleaf Asset Management first reported a position in ADPT in Q2 2024 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Smartleaf Asset Management held 4,393 shares of Adaptive Biotechnologies worth $94K as of Q2 2026.
  • Smartleaf Asset Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1203 holding.
  • Smartleaf Asset Management first reported a position in Adaptive Biotechnologies in Q2 2024 and has held it in 9 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.